These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 5661353)
1. Metabolism of 3-hydroxytyramine (dopamine) in human subjects. Goodall M; Alton H Biochem Pharmacol; 1968 Jun; 17(6):905-14. PubMed ID: 5661353 [No Abstract] [Full Text] [Related]
2. Dopamine (3-hydroxytyramine) metabolism in parkinsonism. Goodall M; Alton H J Clin Invest; 1969 Dec; 48(12):2300-8. PubMed ID: 5355341 [TBL] [Abstract][Full Text] [Related]
4. 3-O-methyldopa, a new precursor of dopamine. Bartholini G; Kuruma I; Pletscher A Nature; 1971 Apr; 230(5295):533-4. PubMed ID: 4927759 [No Abstract] [Full Text] [Related]
5. Beta-hydroxylation of N-acetyl-3,4-dimethoxyphenethylamine and the influence of iproniazid on the demethylation of this compound in vivo in the rat. Van Winkle E; Schweitzer JW; Friedhoff AJ Biochem Pharmacol; 1970 Jun; 19(6):2137-44. PubMed ID: 5513979 [No Abstract] [Full Text] [Related]
6. Urinary excretion of dopamine and homovanillic acid in acute myocardial infarction. Januszewicz W; Sznajderman M; Wocial B; Preibisz J; Poplawska W Clin Chim Acta; 1971 Apr; 32(2):261-4. PubMed ID: 5122226 [No Abstract] [Full Text] [Related]
7. The effect of tyramine on phenolic acid and alcohol excretion in man. Carter SB; Karoum F; Sandler M; Youdim MB Br J Pharmacol; 1970 May; 39(1):202P-203P. PubMed ID: 5420102 [No Abstract] [Full Text] [Related]
8. Contributions of host and intestinal microflora in the metabolism of L-dopa by the rat. Goldin BR; Peppercorn MA; Goldman P J Pharmacol Exp Ther; 1973 Jul; 186(1):160-6. PubMed ID: 4723308 [No Abstract] [Full Text] [Related]
9. Metabolism of 3,4-dihydroxyphenylacetic acid (DOPAC) in the human. Alton H; Goodall M Biochem Pharmacol; 1969 Jun; 18(6):1373-9. PubMed ID: 5799111 [No Abstract] [Full Text] [Related]
10. Metabolism of tyramine-1-14C by the rat. Tacker M; McIsaac WM; Creaven PJ Biochem Pharmacol; 1970 Oct; 19(10):2763-73. PubMed ID: 5478585 [No Abstract] [Full Text] [Related]
12. The metabolism of L-3-O-methyldopa, a precursor of dopa in man. Kuruma I; Bartholini G; Tissot R; Pletscher A Clin Pharmacol Ther; 1971; 12(4):678-82. PubMed ID: 5567811 [No Abstract] [Full Text] [Related]
13. Dietary migraine and tyramine metabolism. Smith I; Kellow AH; Mullen PE; Hanington E Nature; 1971 Mar; 230(5291):246-8. PubMed ID: 4926715 [No Abstract] [Full Text] [Related]
14. Urinary metabolites from rats given L-DOPA. Borud O; Midtvedt T; Gjessing LR Acta Pharmacol Toxicol (Copenh); 1972; 31(5):540-9. PubMed ID: 4678834 [No Abstract] [Full Text] [Related]
15. Metabolism in the human of 3, 4-dihydroxymandelic acid, one of the metabolites of noradrenaline and adrenaline. Goodall M; Alton H Biochem Pharmacol; 1969 Feb; 18(2):295-302. PubMed ID: 5778148 [No Abstract] [Full Text] [Related]
16. Aspects of tyrosine metabolism in schizophrenia. Williams CH Psychol Med; 1971 Aug; 1(4):286-91. PubMed ID: 5149869 [No Abstract] [Full Text] [Related]
17. A three solvent partition chromatographic technique for the estimation of acid metabolites of catecholamines. Urinary DOMA, DOPAC and HVA. Vahidi A; Siva Sankar DV Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):156-60. PubMed ID: 5524313 [No Abstract] [Full Text] [Related]
18. Effect of cannabis sativa administered by smoking on biogenic amine excretion in man. Messiha FS; Soskin RA Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):325-8. PubMed ID: 4734006 [No Abstract] [Full Text] [Related]
19. Effect of L-dopa therapy on urinary p-tyramine excretion and EEG changes in Parkinson's disease. Boulton AA; Marjerrison GL Nature; 1972 Mar; 236(5341):76-8. PubMed ID: 4553458 [No Abstract] [Full Text] [Related]
20. Metabolism of dihydroxyphenylalanine and tryptophan in pyridoxine-deficient rats. Sourkes TL; Missala K Ann N Y Acad Sci; 1969 Sep; 166(1):235-45. PubMed ID: 5262018 [No Abstract] [Full Text] [Related] [Next] [New Search]